Skip to Content
Merck
CN

Key Documents

View All Documentation

24-1280

1,10-Phenanthroline hydrochloride monohydrate

JIS special grade, ≥99.0%

Synonym(s):

o-Phenanthroline hydrochloride monohydrate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C12H8N2 · HCl · H2O
CAS Number:
18851-33-7
Molecular Weight:
234.68
EC Number:
223-325-1
UNSPSC Code:
12352300
PubChem Substance ID:
329752578
Beilstein/REAXYS Number:
4007967
MDL number:
MFCD00150061
Assay:
≥99.0%
Grade:
JIS special grade
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

grade

JIS special grade

assay

≥99.0%

form

solid

availability

available only in Japan

mp

224-225 °C (lit.)

SMILES string

O.Cl.c1cnc2c(c1)ccc3cccnc23

InChI

1S/C12H8N2.ClH.H2O/c1-3-9-5-6-10-4-2-8-14-12(10)11(9)13-7-1;;/h1-8H;1H;1H2

InChI key

NDLHUHRGAIHALB-UHFFFAOYSA-N

Still not finding the right product?

Explore all of our products under 1,10-Phenanthroline hydrochloride monohydrate

pictograms

Skull and crossbonesEnvironment
GHS06,GHS09

signalword

Danger

hcodes

H301,H410

Hazard Classifications

Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges

Regulatory Information

新产品

This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
U5127
U9859
U5349
U1226
U1182

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

T M-H Nguyen et al.
International journal of pharmaceutics, 482(1-2), 21-26 (2014-12-03)
Hyperphosphatemia is one of the main risk factors contributing to morbidity and mortality in patients with end stage renal disease. The demand for a new phosphate binder is continuously increasing since the number of patients suffering under hyperphosphatemia is growing.